Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 354,062
  • Shares Outstanding, K 174,415
  • Annual Sales, $ 2,020 K
  • Annual Income, $ -17,590 K
  • 60-Month Beta -5.94
  • Price/Sales 62.22
  • Price/Cash Flow N/A
  • Price/Book 58.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/13
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6200 +19.14%
on 09/04/20
2.7800 -30.58%
on 08/25/20
-0.2800 (-12.67%)
since 08/24/20
3-Month
1.5500 +24.52%
on 06/25/20
7.4500 -74.09%
on 07/21/20
+0.3800 (+24.52%)
since 06/24/20
52-Week
0.0500 +3,760.00%
on 11/19/19
7.4500 -74.09%
on 07/21/20
+1.3825 (+252.51%)
since 09/24/19

Most Recent Stories

More News
Companies Rush to Develop Innovative Disinfecting Technologies

, /PRNewswire/ -- The pandemic has drastically reshaped the global social and economic landscape. Countries have shut down schools and businesses, restricted travel, postponed entertainment and sporting...

OPTI : 0.0270 (unch)
VYST : 0.0335 (-9.46%)
TPTW : 0.0590 (+4.42%)
OGEN : 0.6197 (-6.11%)
IBIO : 1.9300 (-4.93%)
Thinking about buying stock in Sorrento Therapeutics, Herman Miller, iBio Inc, TOP Ships, or Aurora Cannabis?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SRNE, MLHR, IBIO, TOPS, and ACB.

ACB : 5.20 (+0.58%)
ACB.TO : 6.91 (+0.14%)
MLHR : 30.33 (+1.57%)
IBIO : 1.9300 (-4.93%)
SRNE : 9.19 (-4.27%)
Diagnostic Devices Give the Healthcare System New Avenues for Innovation

, /PRNewswire/ -- The recent pandemic, which has put a heavy toll on our economy and pushed the healthcare system into a severe scarcity problem, further illustrates the importance of medical devices...

OPK : 3.07 (+0.66%)
NMRD : 3.61 (+1.69%)
IBIO : 1.9300 (-4.93%)
CODX : 13.78 (+2.45%)
NVAX : 102.44 (+0.86%)
Thinking about buying stock in iBio Inc, Virgin Galactic, Sorrento Therapeutics, Adamis Pharmaceuticals, or Plug Power?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, SPCE, SRNE, ADMP, and PLUG.

ADMP : 0.7050 (-4.73%)
IBIO : 1.9300 (-4.93%)
SRNE : 9.19 (-4.27%)
iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic

iBio, Inc. (NYSE AMERICAN:IBIO) ("iBio" or the "Company"), a biotechnology innovator and biologics contract manufacturing organization, today announced that it has entered into an exclusive worldwide license...

IBIO : 1.9300 (-4.93%)
Are COVID-19 Vaccines And Therapeutics Advancing Faster Than Expected

, /PRNewswire/ -- The worldwide response, both private and public, to finding a therapeutic and/or vaccine for the global pandemic has brought out the best in the global community. Contrary to historical...

IBIO : 1.9300 (-4.93%)
JAN : 4.14 (-4.39%)
MRNA : 65.17 (-2.96%)
SRNE : 9.19 (-4.27%)
INO : 15.37 (-3.76%)
Thinking about buying stock in Ibio Inc, Gulfport Energy Corporation, Delta Air Lines, Inc., Autoweb Inc, or Etsy Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, GPOR, DAL, AUTO, and ETSY.

DAL : 29.01 (-1.86%)
ETSY : 113.68 (-1.23%)
GPOR : 0.5409 (-5.11%)
IBIO : 1.9300 (-4.93%)
Thinking about buying stock in Oragenics Inc, Fortress Biotech, Super League Gaming, CleanSpark Inc, or iBio Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OGEN, FBIO, SLGG, CLSK, and IBIO.

FBIO : 3.86 (-2.77%)
IBIO : 1.9300 (-4.93%)
OGEN : 0.6197 (-6.11%)
Times of Global Turmoil Reinforce the Need for Advanced Diagnostic Capabilities

, /PRNewswire/ -- The diagnostics industry is a large and diverse entity, with new innovative technology constantly being developed. Diagnostic tests are usually conducted in laboratories, private or...

CYDY : 3.3565 (-2.14%)
IBIO : 1.9300 (-4.93%)
TOMDF : 0.0839 (-6.36%)
AMBS : 0.0098 (-6.67%)
AYTU : 1.2000 (-6.25%)
PFE : 35.76 (-0.67%)
Thinking about buying stock in Intrepid Potash, iBio Inc, FAT Brands, Precipio Inc, or Norwegian Cruise Line?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IPI, IBIO, FAT, PRPO, and NCLH.

IBIO : 1.9300 (-4.93%)
IPI : 8.89 (+2.77%)
NCLH : 14.63 (-3.56%)
PRPO : 2.19 (-1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade IBIO with:

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

2nd Resistance Point 2.1900
1st Resistance Point 2.0600
Last Price 1.9300
1st Support Level 1.8100
2nd Support Level 1.6900

See More

52-Week High 7.4500
Fibonacci 61.8% 4.6232
Fibonacci 50% 3.7500
Fibonacci 38.2% 2.8768
Last Price 1.9300
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar